AdvanSix (ASIX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
4Q24 sales were $329M, down 14% year-over-year, with adjusted EBITDA of $10M and net income of $0.4M; FY24 sales were $1.52B, down 1%, with adjusted EBITDA of $142M and net income of $44.1M.
Operational disruptions and extended plant turnaround in 4Q24 significantly impacted earnings, partially offset by $9.7M in 45Q carbon capture tax credits and insurance proceeds.
Strong cash flow performance in 4Q24, with $64M cash from operations and $30M free cash flow; FY24 free cash flow was $10M despite challenges.
Final settlement for 2019 PES supplier shutdown: $5.3M insurance proceeds in 4Q24 and $26M in 1Q25, totaling $39M since 2019.
Continued investment in growth initiatives, including SUSTAIN program and granular ammonium sulfate capacity expansion, with prudent debt management.
Financial highlights
4Q24 adjusted EBITDA margin was 3.1%, down from 4.0% in 4Q23; FY24 margin was 9.4%, down from 10.0% in FY23.
4Q24 adjusted EPS was $0.09, up $0.19 sequentially; FY24 adjusted EPS was $1.96, down $0.18 year-over-year.
FY24 cash flow from operations rose to $135.4M, up $17.9M; free cash flow was $1.7M, down $8.5M.
FY24 capex was $134M, up $26M year-over-year, reflecting increased maintenance and enterprise spend.
Year-end debt leverage at 1.1x, improved from 1.2x prior year.
Outlook and guidance
2025 outlook anticipates strong sulfur nutrition demand, tight ammonium sulfate supply, and high sulfur premiums; higher raw material prices expected to impact fertilizer margins.
Balanced global acetone supply and demand expected to support industry spreads above cycle averages.
North American nylon industry recovery expected to be slow amid stable demand and increased competition.
2025 capex expected at $140M–$160M, focused on growth and risk mitigation.
Plant turnaround pre-tax income impact forecasted at $25–$30M in 2025, down from ~$58M in 2024.
Latest events from AdvanSix
- Q4 sales up 9% with Plant Nutrients strength; 2026 focus on cost savings and cash flow.ASIX
Q4 202520 Feb 2026 - Q2 2024 sales and earnings rose on strong nylon, ammonium sulfate, and acetone demand.ASIX
Q2 20242 Feb 2026 - Diversified growth, strong sulfur nutrition demand, and disciplined capital strategy drive outlook.ASIX
CL King’s 22nd Annual Best Ideas Conference 202420 Jan 2026 - Q3 sales up 23% to $398M; $12M USDA grant and Hopewell maintenance impact highlighted.ASIX
Q3 202417 Jan 2026 - Proxy covers director elections, auditor ratification, pay, ESG, and governance reforms.ASIX
Proxy Filing1 Dec 2025 - Proxy covers director elections, auditor, compensation, stock plan, and officer liability amendment.ASIX
Proxy Filing1 Dec 2025 - Board recommends all proxy proposals, including director elections and charter amendment.ASIX
Proxy Filing1 Dec 2025 - Updated voting rules clarify effects of abstentions and non-votes on all annual meeting proposals.ASIX
Proxy Filing1 Dec 2025 - Q1 2025 saw strong sales, profit rebound, and Plant Nutrients growth, aided by insurance proceeds.ASIX
Q1 202528 Nov 2025